Toggle light / dark theme

Scientists Unveil a ‘Brain Decoder’ That Turns Neural Activity Into Speech

The spoken word is a powerful tool, but not all of us have the ability to use it, either due to biology or circumstances. In such cases, technology can bridge the gap — and now that gap is looking shorter than ever, with a new algorithm that turns messages meant for your muscles into legible sounds.

Converting the complex mix of information sent from the brain to the orchestra of body parts required to transform a puff of air into meaningful sound is by no means a simple feat.

The lips, tongue, throat, jaw, larynx, and diaphragm all need to work together in near-perfect synchrony, requiring our brain to become a master conductor when it comes to uttering even the simplest of phrases.

Read more

Injecting CRISPR into fetal brain may correct autism mutations

Researchers are edging closer to a therapy for Angelman syndrome that involves injecting molecules that can edit genes into the fetal brain. They have already succeeded in mice and say the approach could eventually treat people with the syndrome.

The work is of high interest because a similar strategy could also work for other genetic conditions linked to autism.

But the prospect of injecting molecules into fetal brains poses ethical questions, experts caution.

Read more

Scientists propose new theory on Alzheimer’s, amyloid connection

Worldwide, 50 million people are living with Alzheimer’s disease and other dementias. According to the Alzheimer’s Association, every 65 seconds someone in the United States develops this disease, which causes problems with memory, thinking and behavior.

It has been more than 100 years since Alois Alzheimer, M.D., a German psychiatrist and neuropathologist, first reported the presence of senile plaques in an Alzheimer’s patient brain. It led to the discovery of that produces deposits or plaques of fragments in the brain, the suspected culprit of Alzheimer’s disease. Since then, amyloid has been extensively studied because of its association with Alzheimer’s disease. However, amyloid precursor protein distribution within and on neurons and its function in these cells remain unclear.

A team of neuroscientists led by Florida Atlantic University’s Brain Institute sought to answer a fundamental question in their quest to combat Alzheimer’s disease—” Is amyloid precursor protein the mastermind behind Alzheimer’s disease or is it just an accomplice?”

Read more

Synthetic molecule shows promise as multiple sclerosis treatment

In multiple sclerosis, the body’s immune system attacks and damages myelin, which is the insulating layer on nerves in the spinal cord, brain and optic nerve. This causes the nerves to short-circuit and cease functioning properly. In “a potential game-changer,” scientists have now demonstrated that a synthetic molecule can restore compromised myelin.

Read more

The Origins of Us: Evolutionary Emergence and The Omega Point Cosmology — A New Book That Makes You Question The Nature of Reality but Provides You with Surprising Answers | Press Release

Ecstadelic Media Group releases a new non-fiction book The Origins of Us: Evolutionary Emergence and The Omega Point Cosmology by Alex M. Vikoulov as a Kindle ebook (Press Release, San Francisco, CA, USA, April 22, 2019 01.00 PM PST)

The Science and Philosophy of Information book series is adapted for general audience and based on the previously published grand volume titled The Syntellect Hypothesis: Five Paradigms of the Mind’s Evolution” by digital philosopher Alex Vikoulov on the ultimate nature of reality, consciousness, the physics of time, and philosophy of mind. In this book one of the series, the author addresses some of the most flaming questions in science and philosophy: Where do we come from? What are the origins of us? What is our role in the grand scheme of things?

# 1 Hot New Release” in Amazon charts in Cosmology and Evolution, the book starts with a story that happened almost exactly 400 years ago that has had a tremendous “butterfly” effect on us modern humans.


The University Is Proud and Congratulates Its Graduate Dr. Thabat Al-khatib and Researcher in Applied Neuroscience for Receiving Two Patents of Medicine for the Treatment of Alzheimer’s Disease

Arab American University congrats and is proud of Dr. Thabat Al-Khatib and researcher in Applied Neuroscience, Dr. Al-Khatib graduated from the Faculty of Sciences and Arts at Arab American University in 2012. She succeeded to add her name on the list of innovators in Britain after the invention of a drug treatment for Alzheimer’s disease and received two patents.

Al Khatib is currently working at the University of Aberdeen – Faculty of Medicine as a researcher in Neuroscience dept. and aspires to be a lecturer in Palestine to add value to students and the community.

Al-Khatib said commenting on the two inventions:

Read more